| abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to biotechnology, specifically to production of modified exotoxins Pseudomonas, and can be used in medicine for anticancer therapy. Exotoxin A Pseudomonas (PE) is obtained, in which the amino acid residue R456 is substituted with alanine, one or combined with F443, substituted with alanine, L477, substituted with histidine, R494, substituted with alanine, and/or L552, substituted with glutamic acid or asparagine. Modified PE is used to produce chimeric molecules containing an agent fused with PE or conjugated with PE, which targets a target target cell. n EFFECT: invention enables to obtain exotoxin A Pseudomonas with reduced immunogenicity while maintaining cytotoxicity. n 42 cl, 27 dwg, 28 ex, 31 tbl |